C/EBPα transcription factor is regulated by the RANK cytoplasmic 535IVVY538 motif and stimulates osteoclastogenesis more strongly than c-Fos
Open Access
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (4) , 1480-1492
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01-AR-44741, R01-DE-023813, R01-AR-070135)
This publication has 55 references indexed in Scilit:
- C/EBPα regulates osteoclast lineage commitmentProceedings of the National Academy of Sciences, 2013
- Molecular Basis of Requirement of Receptor Activator of Nuclear Factor κB Signaling for Interleukin 1-mediated OsteoclastogenesisJournal of Biological Chemistry, 2012
- TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-JJournal of Experimental Medicine, 2012
- Development of Cell-Based High-Throughput Assays for the Identification of Inhibitors of Receptor Activator of Nuclear Factor-Kappa B SignalingASSAY and Drug Development Technologies, 2011
- Receptor Activator of NF-κB (RANK) Cytoplasmic IVVY535–538 Motif Plays an Essential Role in Tumor Necrosis Factor-α (TNF)-mediated OsteoclastogenesisJournal of Biological Chemistry, 2010
- Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesisNature Medicine, 2009
- Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclastsBiochemical Journal, 2008
- Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) MutationsThe American Journal of Human Genetics, 2008
- Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescenceHuman Molecular Genetics, 2007
- Osteoclast differentiation and activationNature, 2003